Printer friendly
"AcronymFinder.com

What does NEOP stand for?

NEOP stands for Neoprobe Corporation (stock symbol)

This definition appears frequently and is found in the following Acronym Finder categories:

  • Business, finance, etc.

See other definitions of NEOP

Other Resources:
We have 5 other meanings of NEOP in our Acronym Attic

Samples in periodicals archive:

Neoprobe Corporation (OTC Bulletin Board: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products today announced that CEO David Bupp, will present at the BIO CEO & Investor Conference at the Waldorf Astoria Hotel, Jade Suite in New York on Tuesday February 24, 2004 at 3:30 PM ET.
Mark Pykett to Provide Corporate, Drug Pipeline Updates - DUBLIN, Ohio -- Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that Dr.
19 /PRNewswire/ -- United States Surgical Corporation (NYSE: USS) today announced that it has signed an exclusive agreement with Neoprobe Corporation (Nasdaq-NNM: NEOP, NEOPW) for exclusive worldwide sales and distribution rights for Neoprobe's RIGS* (radioimmuno- guided surgery) products for surgical detection and treatment of cancer.
The corrected release reads: NEOPROBE TO PRESENT AT WALL STREET ANALYST FORUM; CFO TO PROVIDE BUSINESS UPDATE Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its Vice President, Finance and Chief Financial Officer, Brent Larson, will present tomorrow, September 28, 2006 at 11:10 a.
DUBLIN, Ohio -- Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Wednesday, July 19, 2006 and on Thursday, July 20, 2006 at the Friedland Investment Biotech, Medical and Healthcare Luncheon Meetings in New York and Boston, respectively.
DUBLIN, Ohio -- Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that it has initiated its Phase 2 multi-center clinical study of Lymphoseek(TM), a lymphatic tissue targeting agent being developed by the Company.